New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2013
07:45 EDTACORAcorda Therapeutics downgraded to Neutral from Buy at MKM Partners
MKM Partners downgraded Acorda due to valuation. Price target is $31.
News For ACOR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 15, 2014
07:08 EDTACORAcorda Therapeutics announces initiation of Phase 3 dalfampridine trial
Subscribe for More Information
December 10, 2014
07:02 EDTACORAcorda Therapeutics announces initiation of Phase 3 CVT-301 trial
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use